Samjin to transfer a technology of anti-AIDS virus.

Published: 2005-10-19 06:57:00

Updated: 2005-10-19 06:57:00

Samjin pharmaceutical company announced on Oct. 14 that the company had agreed with Imquest Pharmaceuticals in the United States to transfer the anti-AIDS virus compound "SJ-3366" which was developed and patented by Samjin under the exclusive and packaged technology transfer agreement.

Samjin said that the objective of the above technology transfer purported to speed up its clinical research...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.